These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19119118)

  • 1. Eruptive keratoacanthoma following topical imiquimod for in situ squamous cell carcinoma of the skin in a renal transplant recipient.
    Pini AM; Koch S; Schärer L; French LE; Läuchli S; Hofbauer GF
    J Am Acad Dermatol; 2008 Nov; 59(5 Suppl):S116-7. PubMed ID: 19119118
    [No Abstract]   [Full Text] [Related]  

  • 2. Bowen's disease in a renal transplant recipient treated with a single application of topical imiquimod: severe adverse skin reaction with favourable clinical outcome.
    Casanova D; Martignoni G; Boccaletti V; Di Nuzzo S
    Acta Biomed; 2012 Apr; 83(1):81-3. PubMed ID: 22978064
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of imiquimod in the treatment of periocular tumours.
    Ross AH; Kennedy CT; Collins C; Harrad RA
    Orbit; 2010 Apr; 29(2):83-7. PubMed ID: 20394545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imiquimod 5% cream in the treatment of Bowen's disease and invasive squamous cell carcinoma.
    Peris K; Micantonio T; Fargnoli MC; Lozzi GP; Chimenti S
    J Am Acad Dermatol; 2006 Aug; 55(2):324-7. PubMed ID: 16844522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ophthalmic side-effects of imiquimod therapy in the management of periocular skin lesions.
    Cannon PS; O'Donnell B; Huilgol SC; Selva D
    Br J Ophthalmol; 2011 Dec; 95(12):1682-5. PubMed ID: 20702431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Photodynamic therapy vs imiquimod].
    Serra-Guillén C; Nagore E; Guillén C
    Actas Dermosifiliogr; 2012; 103(6):488-501. PubMed ID: 22178262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hearing loss in association with topical imiquimod use for squamous cell carcinoma in situ (Bowen disease).
    Rodrigues M; Gamboni SE; Cousins VC; Nixon RL
    Australas J Dermatol; 2016 Nov; 57(4):323-324. PubMed ID: 27885662
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of multiple lesions of Bowen's disease and squamous cell carcinoma with topical imiquimod.
    Palungwachira P; Palungwachira P; Ogawa H
    J Dermatol; 2005 Dec; 32(12):1005-9. PubMed ID: 16471467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bowen's disease of the penis treated with topical imiquimod 5% cream.
    Taliaferro SJ; Cohen GF
    J Drugs Dermatol; 2008 May; 7(5):483-5. PubMed ID: 18505144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone invasion by squamous cell carcinoma in situ (Bowen's disease) of the finger during treatment with imiquimod 5% cream: case report.
    Gong HS; Cho JH; Roh YH; Chung MS; Baek GH
    J Hand Surg Am; 2010 Jun; 35(6):999-1002. PubMed ID: 20378275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Bowen's disease using a cycle regimen of imiquimod 5% cream.
    Chen K; Shumack S
    Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():10-2. PubMed ID: 14616804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of penile Bowen's disease with 5% imiquimod cream.
    Poluri RM; Higgins SP
    Int J STD AIDS; 2005 Sep; 16(9):649. PubMed ID: 16176641
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of Bowen's disease with topical 5% imiquimod cream: retrospective study.
    Rosen T; Harting M; Gibson M
    Dermatol Surg; 2007 Apr; 33(4):427-31; discussion 431-2. PubMed ID: 17430376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Squamous cell carcinoma in situ (Bowen's disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy.
    Smith KJ; Germain M; Skelton H
    Dermatol Surg; 2001 Jun; 27(6):561-4. PubMed ID: 11442593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexisting perianal squamous cell carcinoma, Bowen's disease, and condylomata acuminata treated with topical imiquimod 5%.
    Murua AA; González LC; García-Río I; Urra IT; Michelena IA; González-Pérez R; Santarén BC; Arechavala RS
    Int J Dermatol; 2008 Dec; 47(12):1334-6. PubMed ID: 19126041
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of Imiquimod 3.75% for the treatment of extensive Bowen's disease of the face in an elderly patient.
    Robustelli Test E; Fumo G; Corbeddu M; Ferreli C; Rongioletti F
    Dermatol Ther; 2020 Mar; 33(2):e13263. PubMed ID: 32049407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Retinoids in the treatment of epithelial skin tumors].
    Berretti B; Grupper C
    Ther Umsch; 1986 Sep; 43(9):703-6. PubMed ID: 3535155
    [No Abstract]   [Full Text] [Related]  

  • 18. [Actinic keratosis, Bowen's disease, keratoacanthoma and squamous cell carcinoma of the skin].
    Majores M; Bierhoff E
    Pathologe; 2015 Feb; 36(1):16-29. PubMed ID: 25663185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imiquimod for superficial and in situ skin malignancy.
    Drug Ther Bull; 2009 Oct; 47(10):113-6. PubMed ID: 19809085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imiquimod 5 percent cream and the treatment of cutaneous malignancy.
    Navi D; Huntley A
    Dermatol Online J; 2004 Jul; 10(1):4. PubMed ID: 15347486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.